Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-281-4 | CAS number: 98362-33-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2012-04-24 to 2012-05-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
- Version / remarks:
- 2009
- Deviations:
- yes
- Remarks:
- In the study plan it was indicated (erroneously) that the study plan was drafted according to the OECD 413 guideline. Because the present study was a concentration range finding study not all aspects of the guideline were implemented.
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with toluene-4-sulfonic acid
- EC Number:
- 500-281-4
- EC Name:
- 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with toluene-4-sulfonic acid
- Cas Number:
- 98362-33-5
- Molecular formula:
- Exact identification is not feasible
- IUPAC Name:
- Copolymer of neodecanoic acid oxiranylmethyl ester and 4-methylbenzenesulfonic acid
- Reference substance name:
- Copolymer of neodecanoic acid oxiranylmethyl ester and 4 -methylbenzenesulfonic acid
- IUPAC Name:
- Copolymer of neodecanoic acid oxiranylmethyl ester and 4 -methylbenzenesulfonic acid
- Reference substance name:
- DYNAPOL CATALYST 1203 (solvent free)
- IUPAC Name:
- DYNAPOL CATALYST 1203 (solvent free)
- Test material form:
- other: liquid
- Details on test material:
- Appearance : slightly yellowish liquid
Purity1 : >99%
Batch number : VP BL-PTSA-Kat.1106
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- - Source: Harlan, netherlands
- Strain: rats, Wistar (RccHan:WIST)
- Age: approx. 8 weeks on first exposure day
- Animals: 24 males
- Acclimatisation: 12 days
- Mean Body Weight at study initiation: male: 260g
- Housing: 3 animals to a macrolon cage
- Diet: ad libitum, rodent diet (Rat & Mouse No. 3 Breeding Diet, RM3) from SDS Special Diets Services, Whitham, England
- Water: tap water ad libitum
- Temperature (°C): 22 +/- 2 °C,
- Humidity: about 45 - 65%
- Illumination: 12 hours artifical fluorescent light and 12 hours dark
- Air exchange: 10 per hour
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: humdified compressed air
- Remarks on MMAD:
- MMAD / GSD: The average mass median aerodynamic diameter (MMAD) for the low, mid and high concentration groups was 1.29, 1.49 and 2.45 µm, with
corresponding average geometric standard deviations (gsd) of 2.11, 2.40 and 2.13, respectively. - Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: see attachment, nose-only inhalation units (a modification of the chamber manufactured by ADG Developments Ltd.,
Codicote, Hitchin, Herts, SG4 8UB, United Kingdom;
- Method of holding animals in test chamber: animals were secured in plastic animal holders (Battelle), positioned radially through the outer cylinder
around the central column
- Source of air: humdified compressed air, 22 +/- 2 °C, humidity between 30 and 70 %
- Air flow: at least 1 litre/min for each rat,
- System of generating particulates/aerosols: An amount of test material, controlled by a syringe pump (groups 2 and 3) or a peristaltic pump
(group 4), was nebulized using an air-driven atomizer (Schlick type 970/S, Coburg, Germany) which was wrapped up in electric heating tape and
aluminium foil (the test material was too viscous for atomizing without heating) . The atomizer was supplied with a stream of humidified air. The
pressure was regulated by a reducing valve and the flow was measured with a mass stream meter (MASSVIEW from Bronkhorst Hi Tec, Ruurlo, The
Netherlands). The top section of the exposure unit was cooled by one or two plastic pots containing dry ice.
- Temperature, humidity in air chamber: 20.0 to 24.3 °C, humidity: 29.0 to 46.3 5%,
- Air flow rate: The total air flow, temperature and relative humidity were recorded hourly during exposure. The air flow was monitored by a mass
stream meter (MASSVIEW from Bronkhorst Hi Tec, Ruurlo, The Netherlands).
- Method of particle size determination: using a 10-stage cascade impactor (2110k, Sierra instruments, Carmel Valley, California, USA),
- Control group: The exposure chamber for the control animals (group 1) was supplied with a stream of humified air only
TEST ATMOSPHERE
- Analyses of dust particleize: once weekly and at least once during preliminary generation of the test atmosphere for each exposure condition
- Graimetric analyses: The actual concentration of the test material in the test atmosphere was determined at least three times per day for each
exposure condition by gravimetric analysis - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Representative test atmosphere samples were obtained from the animals’ breathing zone during the study by passing mass flow controlled amounts of test atmosphere (230, 23 and 4.6 Ln , corresponding to about 250, 25 and 5 L, at the low, mid and high concentration, respectively) at 4.6 Ln/min through fiber glass filters. Filters were weighed before and after sampling. The actual concentration was calculated by dividing the amount of test material present on the filter by the volume of the sample taken.
- Duration of treatment / exposure:
- 5 days per week for 2 weeks
- Frequency of treatment:
- 5 days/week x 6 hours/day
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
20, 200, 2000 mg/m³
Basis:
other: Target concentration
- Remarks:
- Doses / Concentrations:
31, 202, 2032 mg/m³
Basis:
analytical conc.
- No. of animals per sex per dose:
- 6 males per dose, 4 doses (incl. control)
24 males - Control animals:
- yes, concurrent vehicle
- Details on study design:
- The concentration levels were chosen in consultation with the sponsor.
Male rats were chosen since the results of an acute study with this test material (TNO Triskelion study 9901/12) did not show sex differences and a selection of a single sex with more animals per group increases the statistical power - Positive control:
- not nesessary
Examinations
- Observations and examinations performed and frequency:
- - Animal observations: All animals, before and after the exposure, on days without exposure once a day. All abnormalities, signs of ill health, and
reactions to treatment were recorded.
- Body weights: The body weight of each animal was recorded 1 day before the start of exposure and prior to exposure on the first day (day 0).
Subsequently, animals were weighed on day 1, 3, 7, 10 and 14
- Food consumption: measured per cage by weighing the feeders. The results were expressed in g per animal per day. Food consumption was
measured over the periods day 0-1, 1-7 and 7-14. - Sacrifice and pathology:
- - Necropsy with gross pathological examination: All animals on Day 15.
- Organ weight determination: All animals, fresh weights of heart, adrenals, testes, kidneys, lungs with trachea and larynx, livers and spleens at
necropsy.
- Tissue preservation: The organs were preserved in a neutral aqueous phosphate-buffered 4 per cent solution of formaldehyde
(10% solution of formalin). They will be discarded after completion of the final report. - Other examinations:
- no other examinations
- Statistics:
- - Body weight data: ‘Ancova & Dunnett’s Test’
- Pretreatment and terminal body weights, weight changes and organ weight data: ‘Generalised Anova/Ancova Test’
- Food consumption results (experimental unit is the cage): Dunnett’s multiple comparison test.
Arithmetic means and standard deviations (abbreviation SD) are given in the tables of continuous and semi-continuous data. Tests are performed as
two-sided tests with results taken as significant where the probability of the results is <0.05 or <0.01. Because numerous variables are subjected to statisticalanalysis, the overall false positive rate (Type I errors) is greater than suggested by a probability level of 0.05. Therefore, the final
interpretation of results is based not only on statistical analysis but also on other considerations such as dose-response relationships and whether the
results are significant in the light of other biological and pathological findings
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- details see below
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- details see below
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- details see below
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- details see below
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- details see below
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- details see below
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- - Clinical signs
All animals survived until scheduled sacrifice. The observations made about halfway each exposure day showed no abnormalities. The observations before and after exposure revealed clinical signs in animals of the high concentration group only, namely dyspnoea (4 animals) and
blepharospasm (2 animals) after the first exposure, and grunting (1 animal) prior to exposure on days 8-9. These clinical signs were considered to be related to treatment.
- Body weight
In the second week of the study, growth was reduced, concentration-dependently, in all groups exposed to the test material. This effect was most
marked on the days that the animals were exposed. Between days 7 and 10 (3 successive exposure days) most animals of the mid and high
concentration groups lost weight and the animals of the low concentration group gained less weight than controls. In the period day 10-14
(no exposure on days 11 and 12), all exposed animals gained weight but statistically significantly less than controls.
The weight change results in the first exposure week were confounded by wide interanimal variation which probably resulted from the switch from pelleted to powdered feed on the day before initiation of treatment. Consequently, it is not clear whether or not growth was affected by treatment in the first exposure week.
Compared to the control group, the mean terminal body weights in the low, mid and high concentration group were decreased by 2%, 6% and 4%,
respectively. The differences in mean body weight did not reach the level of statistical significance at any time point.
- Food consumption
On the first exposure day, animals of the high concentration group consumed less food than controls. In the period day 1-7, food consumption of treated animals and controls was comparable. Thereafter, the treated animals tended to eat somewhat less than controls but the differences showed no concentration-related response and, except in the mid concentration group, they were not statistically significant.
- Organ weights
The weight of the lungs (absolute and relative) and kidneys (relative only were statistically significantly increased in the high concentration group.
The weights of the other organs were not affected. In the absence of a similar change in the high concentration group, the statistically significantly
lower liver weight (absolute and relative) observed in the mid concentration group was considered to be unrelated to treatment.
- Macroscopic examination
Macroscopic observations at scheduled sacrifice showed incompletely collapsed lungs in two animals and patches on the lungs in one animal of the high concentration group. These findings were possibly related to treatment.
The other findings were unremarkable. They represent normal background pathology in rats of this strain and age and occurred only incidentally.
Effect levels
- Dose descriptor:
- NOAEC
- Effect level:
- 202 mg/m³ air
- Based on:
- test mat.
- Sex:
- male
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
no remarks
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study no adverse effects occurred in the low and mid concentration groups. Therefore, the mid concentration of
202 mg/m3 (actual concentration measured by gravimetry) was a No-Observed-Adverse-Effect-Concentration (NOAEC) of 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with toluene-4-sulfonic acid . - Executive summary:
The objective of this study was to provide data on the sub-acute (15-day) toxicity in rats of the test item after exposure by inhalation. The results of this 15-day study may serve as a basis for selection of the concentration levels for a future sub-chronic (90-day) inhalation study with this substance.
The inhalation toxicity of the test item was studied in a sub-acute (15-day) inhalation toxicity study in Wistar rats. Four groups of 6 male rats were exposed nose-only to target concentrations of 0 (control) 20, 200 or 2000 mg/m3 of the test material for 6 hours/day, 5 days/week over a 15-day period, with a total of 10 exposure days. Observations and measurements to detect adverse effects included daily clinical observations, body weight, food consumption, organ weights and macroscopic examination at sacrifice on the day after the last exposure.
The mean actual concentrations (± standard deviation) of the test item (solvent free), based on gravimetric analysis, were 31 (± 16), 202 (± 10) and 2032 (± 139) mg/m3 for the low, mid and high concentration level, respectively. The average particle size (Mass Median Aerodynamic Diameter; MMAD) was 1.29 µm (with a geometric standard derviation (gsd) of 2.11), 1.49 µm (gsd of 2.40) and 2.45 µm (gsd of 2.13) for the low, mid and high concentration test atmospheres, respectively.
All animals survived until scheduled sacrifice. Treatment-related clinical signs were seen in the high concentration group only and consisted of dyspnoea (4 animals) and blepharospasm (2 animals) after the first exposure, and grunting (1 animal) prior to exposure on days 8-9.
In the second week of the study, growth was reduced, concentration-dependently, in all groups exposed to the test material. This effect was most marked on the days that the animals were exposed (between days 7 and 10, most animals of the mid and high concentration groups lost weight). Growth data of the first week were inconclusive due to wide inter animal variation which probably resulted from the switch from pelleted to powdered feed on the day before initiation of treatment. Despite the effect on growth, mean body weights showed no statistically significant intergroup differences. Therefore, the effect on growth was considered to be of little toxicological significance.
Food consumption was decreased on the first exposure day in the high concentration group and, to a limited degree, in the second week in all exposed groups.
Absolute and relative lung weight and relative kidney weight were statistically significantly increased in the high concentration group.
Macroscopic examination at scheduled sacrifice showed incompletely collapsed lungs (two animals) and patches on the lung (one animal) in the high concentration group.These findings were possibly related to treatment.
Conclusion
Under the conditions of this study no adverse effects occurred in the low and mid concentration groups. Therefore, the mid concentration of 202 mg/m3 (actual concentration measured by gravimetry) was a No-Observed-Adverse-Effect-Concentration (NOAEC) of 2,3-Epoxypropyl neodecanoate, oligomeric reaction products with toluene-4-sulfonic acid
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
